Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples

Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples

Abstract Background Monitoring hemophilia treatment with extended half‐life products is challenging for coagulation laboratories since factor assays may show substantial differences between results obtained with the one‐stage assay (OSA) and the chromogenic substrate assay (CSA). Objectives The aim...

Full description

Bibliographic Details
Main Authors: Cecilia Augustsson, Eva Norström, Nadine Gretenkort Andersson, Eva Zetterberg, Jan Astermark, Karin Strandberg
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
blood coagulation tests
coagulants
drug monitoring
factor IX
factor VIII
hemophilia A
Online Access:https://doi.org/10.1002/rth2.12421

Internet

https://doi.org/10.1002/rth2.12421

Similar Items